Wednesday, November 18, 2026 Vol. I · No. 6
Science · Via Phys.org

Stem cell–derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice

Image: Phys.org

In people with type 1 diabetes, the immune system mistakenly identifies insulin-producing cells in the pancreas as foreign and attacks them, leaving the body unable to properly regulate blood sugar. While insulin therapy helps manage the disease, it does not stop the underlying immune attack.

This is a brief. The reporting belongs to Phys.org — read the complete story, with full context and credits, at the source.

Read the full story at Phys.org ↗

phys.org

More from the Science desk